Trelagliptin Path: From regulatory setbacks in the west to approval in India
Crossref DOI link: https://doi.org/10.30574/wjbphs.2025.21.3.0258
Published Online: 2025-03-30
Update policy: https://doi.org/10.30574/wjbphs.ourcrossmarkpolicy
Rashmi Chandra,
Ravi Kumar,
Shoebul Haque,
D. K. Katiyar,
